| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARTICLES |
Gene Expression by Estrogen in Estrogen Receptor-Containing Breast Cancer Cells via Upstream Half-Palindromic Estrogen Response Element Motifs
Departments of Molecular and Integrative Physiology, Cell and Structural Biology, University of Illinois and College of Medicine, Urbana, Illinois 61801
Address all correspondence and requests for reprints to: Dr. Benita S. Katzenellenbogen, Department of Molecular and Integrative Physiology, 524 Burrill Hall, 407 South Goodwin Avenue, University of Illinois, Urbana, Illinois 61801-3704. E-mail: katzenel{at}uiuc.edu
Prothymosin
(PT
), a protein associated with cell
proliferation and chromatin remodeling, and found to selectively
enhance ER transcriptional activity by interacting with a repressor of
ER activity, is shown to be a primary response gene to estrogen.
Prothymosin
mRNA was rapidly increased by estrogen, followed by a
6-fold increase in prothymosin
protein content in ER-containing
breast cancer cells. Analysis of the prothymosin
promoter and
5'-flanking region, and electrophoretic gel mobility shift studies
showed the strong inducibility by the estradiol-ER complex to be
mediated by two consensus half-palindromic estrogen response elements
at -750 and -1051, which directly bind the ER. Estrogenic stimulation
of prothymosin
required a DNA binding form of ER with a functional
activation function-2 domain. The prothymosin
5'-regulatory region
also contains multiple Sp1 sites. Although addition of Sp1 did not
further enhance estradiol-ER stimulated prothymosin
transcriptional
activity in breast cancer cells, transfection and response element
mutagenesis studies using Drosophila cells, which are deficient in Sp1,
revealed that Sp1 and the estradiol occupied-ER can each activate the
prothymosin
gene independently of the other and act in an additive
manner. These observations, documenting robust prothymosin
up-regulation by the estradiol-ER complex via widely spaced
half-palindromic estrogen response element motifs, are reminiscent of
those shown previously for the ovalbumin gene and suggest that the use
of multiple half response elements may be a more common mode for
regulation of gene expression by the ER than previously appreciated. In
addition, these observations suggest interrelationships between cell
proliferation and gene transcriptional activities and indicate a
positive mechanism by which PT
, which increases ER transcriptional
effectiveness, is itself up-regulated by the estrogen-ER
complex.
This article has been cited by other articles:
![]() |
I. Sakata, T. Tanaka, M. Yamazaki, T. Tanizaki, Z. Zheng, and T. Sakai Gastric estrogen directly induces ghrelin expression and production in the rat stomach. J. Endocrinol., September 1, 2006; 190(3): 749 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, L. L. Sullivan, S. S. Nair, C. C. Williams, A. K. Pandey, L. Marrero, R. K. Vadlamudi, and F. E. Jones Coregulation of Estrogen Receptor by ERBB4/HER4 Establishes a Growth-Promoting Autocrine Signal in Breast Tumor Cells Cancer Res., August 15, 2006; 66(16): 7991 - 7998. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haeger, M. E. Andres, M. I. Forray, C. Daza, S. Araneda, and K. Gysling Estrogen receptors alpha and beta differentially regulate the transcriptional activity of the Urocortin gene. J. Neurosci., May 3, 2006; 26(18): 4908 - 4916. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Bryant, M. A. Gibson, and M. A. Shupnik Stimulation of the Novel Estrogen Receptor-{alpha} Intronic TERP-1 Promoter by Estrogens, Androgen, Pituitary Adenylate Cyclase-Activating Peptide, and Forskolin, and Autoregulation by TERP-1 Protein Endocrinology, January 1, 2006; 147(1): 543 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-E. Park, J. Xu, A. Frolova, L. Liao, B. W. O'Malley, and B. S. Katzenellenbogen Genetic Deletion of the Repressor of Estrogen Receptor Activity (REA) Enhances the Response to Estrogen in Target Tissues In Vivo Mol. Cell. Biol., March 1, 2005; 25(5): 1989 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O'Lone, M. C. Frith, E. K. Karlsson, and U. Hansen Genomic Targets of Nuclear Estrogen Receptors Mol. Endocrinol., August 1, 2004; 18(8): 1859 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bourdeau, J. Deschenes, R. Metivier, Y. Nagai, D. Nguyen, N. Bretschneider, F. Gannon, J. H. White, and S. Mader Genome-Wide Identification of High-Affinity Estrogen Response Elements in Human and Mouse Mol. Endocrinol., June 1, 2004; 18(6): 1411 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lai, D. C. Harnish, and M. J. Evans Estrogen Receptor {alpha} Regulates Expression of the Orphan Receptor Small Heterodimer Partner J. Biol. Chem., September 19, 2003; 278(38): 36418 - 36429. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ciana, S. Ghisletti, P. Mussi, I. Eberini, E. Vegeto, and A. Maggi Estrogen Receptor {alpha}, a Molecular Switch Converting Transforming Growth Factor-{alpha}-mediated Proliferation into Differentiation in Neuroblastoma Cells J. Biol. Chem., August 22, 2003; 278(34): 31737 - 31744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Harendza, D. H. Lovett, U. Panzer, Z. Lukacs, P. Kuhnl, and R. A. K. Stahl Linked Common Polymorphisms in the Gelatinase A Promoter Are Associated with Diminished Transcriptional Response to Estrogen and Genetic Fitness J. Biol. Chem., May 30, 2003; 278(23): 20490 - 20499. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Ediger, S.-E. Park, and B. S. Katzenellenbogen Estrogen Receptor Inducibility of the Human Na+/H+ Exchanger Regulatory Factor/Ezrin-Radixin-Moesin Binding Protein 50 (NHE-RF/EBP50) Gene Involving Multiple Half-Estrogen Response Elements Mol. Endocrinol., August 1, 2002; 16(8): 1828 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, Y. R. Huang, W. R. Harrington, S. Sheng, J. A. Katzenellenbogen, and B. S. Katzenellenbogen Antagonists Selective for Estrogen Receptor {alpha} Endocrinology, March 1, 2002; 143(3): 941 - 947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |